President Droupadi Murmu on April 4 launched India’s first indigenously-developed CAR T-cell therapy for treatment of cancer, hailing it as a “major breakthrough” that provides a “new hope for the humankind” in the battle against the disease.
During the launch event held at the Indian Institute of Technology (IIT) Bombay located in Powai in Mumbai, she also said the development of this therapy is an example of the ‘Make in India’ initiative.
Developed by the IIT Bombay and the Tata Memorial Centre, this gene-based therapy will help in curing different types of cancer. This NexCAR19 CAR T-cell therapy is the country’s first ‘Made in India’ CAR T-cell therapy, which will significantly bring down the cost of cancer treatment.
